Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Presentation TVT 2019

Renal Vein Pressure Decompression for ADHF (Magenta)

Presenter: Ori Ben-Yehuda

June 12, 2019

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

Clinical Trial Considerations for Transcatheter TR Therapies

Presenter: Ori Ben-Yehuda

September 23, 2018

Presentation TCT 2018

The Endpoints for Aortic Valve Development

Presenter: Jeroen J. Bax, Martin B. Leon, Ori Ben-Yehuda

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Presenter: Georg Nickenig, Stephan Windecker, Ori Ben-Yehuda

June 22, 2018

Presentation TCT 2017

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

Presenter: Steven F. Bolling, John C Laschinger, Ori Ben-Yehuda

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

Advertisement

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Renal Vein Pressure Decompression for ADHF (Magenta)

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Clinical Trial Considerations for Transcatheter TR Therapies

The Endpoints for Aortic Valve Development

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content